| Financial Year |
March 31 2023 |
| Monetary Funds |
3,276,331,768.98 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
235,545,065.76 |
| Advances to Suppliers |
1,111,162,633.15 |
| Other Receivables |
149,988,212.95 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,309,621,046.62 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
145,791,827.07 |
| Total Current Assets |
7,229,290,554.53 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
3,220,487,053.06 |
| Investment Properties |
987,599,389.85 |
| Fixed Assetes |
3,222,530,326.22 |
| Under-construction Projects |
4,381,073.19 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
180,868,158.74 |
| R&D expenses |
-- |
| Goodwill |
400,000.00 |
| Long-Term Deferred and Prepaid Expenses |
192,469,824.11 |
| Deferred Income Tax Assets |
288,162,623.06 |
| Other Non-Current Assets |
61,052,224.52 |
| Sub-Total of Non-Current Assets |
11,074,502,474.56 |
| Total Assets |
18,303,793,029.09 |
| Short-Term Loans |
1,576,843,992.08 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,238,971,199.07 |
| Accounts Payable |
2,281,616,453.06 |
| Accounts Received In Advance |
26,079,012.99 |
| Employee Compensation Payable |
846,096,225.45 |
| Taxes Payable |
194,328,716.47 |
| Interest Payable |
-- |
| Dividend Payable |
50,850,824.46 |
| Other payables |
1,079,723,792.09 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
388,065,493.10 |
| Other Current Liabilities |
145,271,305.76 |
| Sub-Total of Current Liabilities |
9,027,567,563.54 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
26,400,317.78 |
| Deferred Income Tax Liabilities |
9,358,520.77 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,556,473,104.17 |
| Total Liabilities |
12,584,040,667.71 |
| Paid-In Capital(Or Share Stock) |
406,528,465.00 |
| Capital Surplus |
340,012,667.94 |
| Surplus Reserve |
333,348,333.41 |
| LESS:Treasury Stock |
209,213,370.74 |
| Undistributed Profits |
4,826,325,991.57 |
| Minority Stockholder's Interest |
89,373,873.24 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,630,378,488.14 |
| Owner's Equity（Stockholder's Equity） |
5,719,752,361.38 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
18,303,793,029.09 |
